Agilent announces global distribution agreement with Proscia to accelerate data-driven precision medicine

By Author Proscia | March 9, 2023

Agilent Technologies Inc. announced a multi-year distribution agreement with Proscia to offer a comprehensive digital diagnostic pathology system. Combining Agilent’s pathology staining solutions with Proscia’s Concentriq Dx* enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes.

*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US during the COVID-19 public health emergency. 

Our website uses cookies. By using this site, you agree to its use of cookies.